Global Medical Reit Stock News

Global Medical REIT Inc (GMRE) shares closed today at 0.9% below its 52 week high of $17.30, giving the company a market cap of $1B. The stock is currently up 38.7% year-to-date, up 35.1% over the past 12 months, and up 169.2% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 12.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Global Medical REIT Inc (GMRE) shares closed today at 0.9% below its 52 week high of $17.30, giving the company a market cap of $1B. The stock is currently up 38.7% year-to-date, up 33.4% over the past 12 months, and up 169.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 12.3% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zacks Investment Research lowered shares of Global Medical REIT (NYSE:GMRE) from a hold rating to a strong sell rating in a research note released on Thursday morning, Zacks.com reports. According to Zacks, Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to []

Analysts expect that Global Medical REIT Inc. (NYSE:GMRE) will announce earnings of $0.24 per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Global Medical REITs earnings. The lowest EPS estimate is $0.24 and the highest is $0.25. Global Medical REIT also reported earnings per share of $0.24 []

Global Medical REIT Inc (GMRE) shares closed today at 0.3% below its 52 week high of $17.40, giving the company a market cap of $1B. The stock is currently up 38.5% year-to-date, up 32.3% over the past 12 months, and up 177.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 15.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Global Medical REIT Inc. (NYSE:GMRE) Investment analysts at KeyCorp raised their FY2021 earnings per share estimates for shares of Global Medical REIT in a research note issued on Wednesday, December 8th. KeyCorp analyst J. Sadler now anticipates that the company will post earnings of $0.91 per share for the year, up from their prior []

Global Medical REIT Inc. (NYSE:GMRE) – Research analysts at KeyCorp increased their FY2021 EPS estimates for Global Medical REIT in a note issued to investors on Wednesday, December 8th. KeyCorp analyst J. Sadler now anticipates that the company will earn $0.91 per share for the year, up from their prior forecast of $0.90. KeyCorp has […]

Wall Street analysts forecast that Global Medical REIT Inc. (NYSE:GMRE) will report sales of $29.54 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Global Medical REITs earnings, with estimates ranging from $28.23 million to $30.50 million. Global Medical REIT reported sales of $24.93 million during the same quarter last []

Bank of America Corp DE decreased its position in shares of Global Medical REIT Inc. (NYSE:GMRE) by 2.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 226,479 shares of the companys stock after selling 6,234 shares during the quarter. Bank of America []

UBS Asset Management Americas Inc. boosted its position in Global Medical REIT Inc. (NYSE:GMRE) by 7.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,005 shares of the companys stock after purchasing an additional 4,205 shares during the quarter. UBS Asset Management Americas []

Marshall Wace North America L.P. increased its stake in shares of Global Medical REIT Inc. (NYSE:GMRE) by 67.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 154,464 shares of the companys stock after acquiring an additional 62,354 shares during the quarter. Marshall []

Sound Income Strategies LLC raised its holdings in Global Medical REIT Inc. (NYSE:GMRE) by 38.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 244,734 shares of the companys stock after purchasing an additional 67,681 shares during the period. Sound Income []

Wedbush Securities Inc. boosted its position in shares of Global Medical REIT Inc. (NYSE:GMRE) by 34.3% during the third quarter, Holdings Channel reports. The firm owned 121,644 shares of the companys stock after buying an additional 31,089 shares during the quarter. Wedbush Securities Inc.s holdings in Global Medical REIT were worth $1,788,000 at the end []

Wall Street analysts expect Global Medical REIT Inc. (NYSE:GMRE) to post $29.54 million in sales for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Global Medical REITs earnings, with the highest sales estimate coming in at $30.50 million and the lowest estimate coming in at $28.23 million. Global Medical REIT []

Shares of Global Medical REIT Inc. (NYSE:GMRE) have received an average rating of Buy from the six analysts that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokers that have []